Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers
P Koźmiński, PK Halik, R Chesori… - International journal of …, 2020 - mdpi.com
Methotrexate, a structural analogue of folic acid, is one of the most effective and extensively
used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune …
used drugs for treating many kinds of cancer or severe and resistant forms of autoimmune …
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
K Hoang-Xuan, E Bessell, J Bromberg… - The Lancet …, 2015 - thelancet.com
The management of primary CNS lymphoma is one of the most controversial topics in neuro-
oncology because of the complexity of the disease and the very few controlled studies …
oncology because of the complexity of the disease and the very few controlled studies …
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
K Hoang-Xuan, M Deckert, AJM Ferreri… - Neuro …, 2023 - academic.oup.com
The management of primary central nervous system (PCNSL) is one of the most
controversial topics in neuro-oncology because of the complexity of the disease and the …
controversial topics in neuro-oncology because of the complexity of the disease and the …
Guidelines for the diagnosis and management of primary central nervous system diffuse large B‐cell lymphoma.
The article offers guidelines for the diagnosis and management of primary central nervous
system diffuse large B-cell lymphoma. It informs on symptoms associated with the disease …
system diffuse large B-cell lymphoma. It informs on symptoms associated with the disease …
[HTML][HTML] First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)—a systematic review and individual patient data …
B Kasenda, AJM Ferreri, E Marturano, D Forst… - Annals of …, 2015 - Elsevier
Background To investigate prognosis and effects of first-line therapy in elderly primary
central nervous system lymphoma (PCNSL) patients. Patients and methods A systematic …
central nervous system lymphoma (PCNSL) patients. Patients and methods A systematic …
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup …
A Omuro, O Chinot, L Taillandier… - The Lancet …, 2015 - thelancet.com
Background No standard chemotherapy regimen exists for primary CNS lymphoma,
reflecting an absence of randomised studies. We prospectively tested two promising …
reflecting an absence of randomised studies. We prospectively tested two promising …
Diagnosis and treatment of primary CNS lymphoma
A Korfel, U Schlegel - Nature Reviews Neurology, 2013 - nature.com
Primary CNS lymphoma (PCNSL) is a rare lymphoma that is confined to the CNS, with low
tendency for systemic dissemination and a relatively aggressive course. Outcome in patients …
tendency for systemic dissemination and a relatively aggressive course. Outcome in patients …
Primary central nervous system lymphoma
ER Gerstner, TT Batchelor - Primary Central Nervous System Tumors …, 2011 - Springer
Non-Hodgkin lymphoma rarely presents as an extranodal lymphoma that is restricted to the
CNS known as primary CNS lymphoma (PCNSL). PCNSL can affect multiple parts of the …
CNS known as primary CNS lymphoma (PCNSL). PCNSL can affect multiple parts of the …
High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
M Holdhoff, P Ambady, A Abdelaziz, G Sarai… - Neurology, 2014 - AAN Enterprises
Objective: To evaluate the efficacy of rituximab (R) when added to high-dose methotrexate
(HD-MTX) in patients with newly diagnosed immunocompetent primary CNS lymphomas …
(HD-MTX) in patients with newly diagnosed immunocompetent primary CNS lymphomas …